The point was that Allergan may try to sell their breast implant business, which brings in only $400 million in annual revenue, but is facing hundreds of millions of dollars & euros in future liabilities as hundreds of women globally with textured implants are suing Allergan. Allergan is most likely going to be stuck with the breast implant business because nobody in their right mind is going to buy it.
The rumors of textured breast implants being banned due to safety concerns was nothing more than noise as the FDA has decided they will not ban them. On May 2nd, the FDA said there was not enough evidence of an association with anaplastic large-cell lymphoma. Other countries have banned them but the FDA still stands as the most respected entity when compared to other countries regulatory agencies.
"At this time, the FDA does not believe that, on the basis of all available data and information, the device meets the banning standard set forth in the federal Food, Drug and Cosmetic Act," the FDA said.